-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Raises Price Target to $310

Benzinga·01/09/2026 11:17:34
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price target from $240 to $310.